Innovative medicines and vaccines are more than scientific achievements — they are lifelines that transform the health of individuals and the resilience of societies. By preventing, treating, and curing disease, they empower people to live longer, healthier lives and enable nations to build stronger, more sustainable healthcare systems. The pursuit of innovation, despite immense risks and costs, has become a cornerstone of progress for humanity.
A Journey That Protects Lives
The path to a new medicine is long and uncertain. Out of every 10,000 compounds studied in laboratories, only one or two will eventually reach patients. Even after entering clinical trials, only 10% of candidates succeed. This journey, often spanning 10 to 15 years and costing billions of dollars, reflects the extraordinary commitment required to deliver breakthroughs. Yet the reward is profound: medicines that save lives, restore health, and give families more time together.
Clinical trials, which account for nearly half of pharmaceutical R&D costs, are designed to ensure that every new therapy meets the highest standards of safety and efficacy. These investments demonstrate the industry’s dedication to protecting patients and earning public trust.
Innovation That Benefits Nations
For nations, innovative medicines and vaccines are engines of progress. They reduce the burden of disease, allowing citizens to remain active contributors to society. By extending healthy lifespans, they strengthen workforces, enhance productivity, and reduce long-term healthcare costs. Nations that embrace innovation benefit from healthier populations and more resilient economies.
The pharmaceutical industry is among the most research-intensive sectors globally, investing around 30% of its revenue into R&D — far more than aerospace or electronics. In 2022, the top 50 companies alone invested US$167 billion, with spending projected to exceed US$200 billion by 2025. These investments fuel not only medical breakthroughs but also economic growth, employment, and global collaboration.
Waves of Progress That Transform Lives
The value of innovative medicines and vaccines is reflected in the transformative waves of progress they create. Without Covid‑19 vaccines, life today would look dramatically different. HIV, once a fatal diagnosis, has become a manageable condition through successive breakthroughs. Cancer treatment has advanced with therapies approved for multiple indications, bringing hope to millions. Even incremental innovations — such as pediatric formulations or new delivery methods — play a vital role, making treatments more accessible, improving adherence, and enhancing quality of life across diverse populations.
These advances show that innovation is not a single event but a continuous process that expands possibilities for patients and strengthens healthcare systems.
A Global Commitment
Innovation is not confined to wealthy nations. Increasingly, clinical trials and research are expanding into Asia and other regions, ensuring that breakthroughs address diverse health needs. This global commitment reflects the shared recognition that innovative medicines are essential for tackling today’s health challenges and preparing for tomorrow’s.
Conclusion: Value Through Application, Benefits for All
For individuals, innovative medicines and vaccines restore health, extend life, and uphold dignity. For nations, they strengthen economies, build more resilient healthcare systems, and enable governments to meet the needs of their citizens. They embody the courage to invest in high‑risk research, the discipline to ensure safety and efficacy, and the vision to balance innovation with access.
Crucially, the true value of innovative medicines and vaccines emerges only when they are used and deliver clinical benefits — creating tangible gains for both society and the economy. When setting innovation priorities, it is vital to look beyond price and recognize the enduring value these therapies bring.
With continued growth in R&D investment, the outlook for future breakthroughs remains strong, offering hope not only to patients but also to nations striving for healthier, more resilient societies.
For more information, please contact:
International Research-based Pharmaceutical Manufacturers Association (IRPMA)
9F-8, 188 Nanjing E. Rd., Sec. 5, Taipei 10571, Taiwan
Tel: +886-2-2767-5661 Fax: +886-2-2746-8575
